Characteristic |
25(OH)D <20 ng/mL (n = 186) |
25(OH) ≥20 ng/mL (n = 114) | P value |
---|---|---|---|
Age (years) | 64 (SD 16) | 69 (SD 15) | < 0.01 |
Sex (%) | 0.67 | ||
Female | 41 | 44 | |
Male | 59 | 56 | |
Race (%) | 0.14 | ||
Non-white | 12 | 6 | |
White | 88 | 94 | |
BMI (kg/m2) | 29 (SD 8) | 28 (SD 6) | 0.22 |
SES | 0.09 | ||
Low | 26 | 25 | |
Moderate | 39 | 41 | |
High | 36 | 33 | |
Patient type (%) | 0.21 | ||
Emergent | 16 | 10 | |
Non-emergent | 84 | 90 | |
APACHE II | 17 (SD 9) | 15 (SD 7) | 0.03 |
Hospital LOS (days) | 9 (IQR 6–15) | 9 (IQR 6–12) | 0.32 |
Vitamin D supplementation (%) | < 0.01 | ||
<1000 IU/day | 88 | 72 | |
≥1000 to <4000 IU/day | 12 | 28 | |
25OHD (ng/mL) | 14 (SD 4) | 27 (SD 7) | < 0.001 |
In-hospital mortality (%) | 0.03 | ||
Alive | 80 | 91 | |
Deceased | 20 | 9 | |
Discharge destination (%) | < 0.01 | ||
Non-home | 48 | 29 | |
Home | 52 | 71 |